The usefulness of a newly developed full‐core biopsy needle in liver biopsy
Aim To evaluate the usefulness and safety of a newly developed full‐core biopsy needle. Methods We selected 149 patients who underwent percutaneous liver biopsy at our institution from February 2019 to April 2021. We excluded 35 patients with hepatic fibrosis stage F3 or higher, which made it histop...
Gespeichert in:
| Veröffentlicht in: | Hepatology research 2023-03, Vol.53 (3), p.247-257 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 257 |
|---|---|
| container_issue | 3 |
| container_start_page | 247 |
| container_title | Hepatology research |
| container_volume | 53 |
| creator | Takeuchi, Hirohito Sugimoto, Katsutoshi Kakegawa, Tatsuya Tomita, Yusuke Takahashi, Hiroshi Wada, Takuya Abe, Masakazu Yoshimasu, Yu Matsubayashi, Jun Nagao, Toshitaka Itoi, Takao |
| description | Aim
To evaluate the usefulness and safety of a newly developed full‐core biopsy needle.
Methods
We selected 149 patients who underwent percutaneous liver biopsy at our institution from February 2019 to April 2021. We excluded 35 patients with hepatic fibrosis stage F3 or higher, which made it histopathologically difficult to measure the number of complete portal triads. The patients were divided into two groups as follows: 62 cases with the 18‐G conventional automated needle (TruCore needle: T needle), and 52 cases with the 18‐G full‐core needle (CorVocet needle: C needle). We measured the number of complete portal triads in the liver tissue specimens, and the sum of the length and width of the collected tissues. Moreover, we compared the number of session counts, fragmentations, and complications.
Results
The sum of the length and the width was 12.8 mm (11.2–14.3) and 15.9 mm (13.1–17.3; p |
| doi_str_mv | 10.1111/hepr.13856 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2735172306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2780744633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4476-e593ca847a288c1a7963498761ea456136641efbd9fbed194e7e71c48bd59ca93</originalsourceid><addsrcrecordid>eNp90MFKwzAYB_AgipvTiw8gAS8idDZNmqRHGdMJE0UmeCtp-5V1ZE1N7EZvPoLP6JOYuenBg7kkfPnx5-OP0CkJh8Sfqzk0dkiojPke6hMpoiCk7GXfv6nkAaeM99CRc4swJCKM2CHqUU7jmFPeR_ezOeDWQdnqGpzDpsQK17DWHS5gBdo0UGD_qT_fP3JjAWeVaVznCRQacFVjXa3A7sbH6KBU2sHJ7h6g55vxbDQJpg-3d6PraZAzJngAcUJzJZlQkZQ5USLxSyZScAKKxZxQzhmBMiuSMoOCJAwECJIzmRVxkquEDtDFNrex5rUF95YuK5eD1qoG07o0EjQmIqIh9_T8D12Y1tZ-O69kKBjjlHp1uVW5Nc5ZKNPGVktlu5SE6abkdFNy-l2yx2e7yDZbQvFLf1r1gGzButLQ_ROVTsaPT9vQL3u-hzI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780744633</pqid></control><display><type>article</type><title>The usefulness of a newly developed full‐core biopsy needle in liver biopsy</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Takeuchi, Hirohito ; Sugimoto, Katsutoshi ; Kakegawa, Tatsuya ; Tomita, Yusuke ; Takahashi, Hiroshi ; Wada, Takuya ; Abe, Masakazu ; Yoshimasu, Yu ; Matsubayashi, Jun ; Nagao, Toshitaka ; Itoi, Takao</creator><creatorcontrib>Takeuchi, Hirohito ; Sugimoto, Katsutoshi ; Kakegawa, Tatsuya ; Tomita, Yusuke ; Takahashi, Hiroshi ; Wada, Takuya ; Abe, Masakazu ; Yoshimasu, Yu ; Matsubayashi, Jun ; Nagao, Toshitaka ; Itoi, Takao</creatorcontrib><description>Aim
To evaluate the usefulness and safety of a newly developed full‐core biopsy needle.
Methods
We selected 149 patients who underwent percutaneous liver biopsy at our institution from February 2019 to April 2021. We excluded 35 patients with hepatic fibrosis stage F3 or higher, which made it histopathologically difficult to measure the number of complete portal triads. The patients were divided into two groups as follows: 62 cases with the 18‐G conventional automated needle (TruCore needle: T needle), and 52 cases with the 18‐G full‐core needle (CorVocet needle: C needle). We measured the number of complete portal triads in the liver tissue specimens, and the sum of the length and width of the collected tissues. Moreover, we compared the number of session counts, fragmentations, and complications.
Results
The sum of the length and the width was 12.8 mm (11.2–14.3) and 15.9 mm (13.1–17.3; p < 0.001), and 0.68 mm (0.63–0.74) and 0.82 mm (0.78–0.90; p < 0.001) for the T needle and C needle, respectively. The number of complete portal triads and fragmentation was six (3–8) and 10 (6–13; p < 0.001), and one (1–10) and one (1–3; p < 0.001), for the T needle and C needle, respectively. There was one session count (1–2) in both groups; however, there were significantly higher cases of two sessions with the T needle than that with the C needle (p = 0.018). There were no serious adverse events.
Conclusions
Compared with the conventional needles, the newly developed full‐core needles enabled the acquisition of a larger amount of tissue sample in liver biopsy.</description><identifier>ISSN: 1386-6346</identifier><identifier>EISSN: 1872-034X</identifier><identifier>DOI: 10.1111/hepr.13856</identifier><identifier>PMID: 36355636</identifier><language>eng</language><publisher>Netherlands: Wiley Subscription Services, Inc</publisher><subject>Biopsy ; biopsy needle ; Fibrosis ; full‐core ; Liver ; liver biopsy ; side‐notch ; ultrasound</subject><ispartof>Hepatology research, 2023-03, Vol.53 (3), p.247-257</ispartof><rights>2022 Japan Society of Hepatology.</rights><rights>2023 Japan Society of Hepatology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4476-e593ca847a288c1a7963498761ea456136641efbd9fbed194e7e71c48bd59ca93</citedby><cites>FETCH-LOGICAL-c4476-e593ca847a288c1a7963498761ea456136641efbd9fbed194e7e71c48bd59ca93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhepr.13856$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhepr.13856$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36355636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takeuchi, Hirohito</creatorcontrib><creatorcontrib>Sugimoto, Katsutoshi</creatorcontrib><creatorcontrib>Kakegawa, Tatsuya</creatorcontrib><creatorcontrib>Tomita, Yusuke</creatorcontrib><creatorcontrib>Takahashi, Hiroshi</creatorcontrib><creatorcontrib>Wada, Takuya</creatorcontrib><creatorcontrib>Abe, Masakazu</creatorcontrib><creatorcontrib>Yoshimasu, Yu</creatorcontrib><creatorcontrib>Matsubayashi, Jun</creatorcontrib><creatorcontrib>Nagao, Toshitaka</creatorcontrib><creatorcontrib>Itoi, Takao</creatorcontrib><title>The usefulness of a newly developed full‐core biopsy needle in liver biopsy</title><title>Hepatology research</title><addtitle>Hepatol Res</addtitle><description>Aim
To evaluate the usefulness and safety of a newly developed full‐core biopsy needle.
Methods
We selected 149 patients who underwent percutaneous liver biopsy at our institution from February 2019 to April 2021. We excluded 35 patients with hepatic fibrosis stage F3 or higher, which made it histopathologically difficult to measure the number of complete portal triads. The patients were divided into two groups as follows: 62 cases with the 18‐G conventional automated needle (TruCore needle: T needle), and 52 cases with the 18‐G full‐core needle (CorVocet needle: C needle). We measured the number of complete portal triads in the liver tissue specimens, and the sum of the length and width of the collected tissues. Moreover, we compared the number of session counts, fragmentations, and complications.
Results
The sum of the length and the width was 12.8 mm (11.2–14.3) and 15.9 mm (13.1–17.3; p < 0.001), and 0.68 mm (0.63–0.74) and 0.82 mm (0.78–0.90; p < 0.001) for the T needle and C needle, respectively. The number of complete portal triads and fragmentation was six (3–8) and 10 (6–13; p < 0.001), and one (1–10) and one (1–3; p < 0.001), for the T needle and C needle, respectively. There was one session count (1–2) in both groups; however, there were significantly higher cases of two sessions with the T needle than that with the C needle (p = 0.018). There were no serious adverse events.
Conclusions
Compared with the conventional needles, the newly developed full‐core needles enabled the acquisition of a larger amount of tissue sample in liver biopsy.</description><subject>Biopsy</subject><subject>biopsy needle</subject><subject>Fibrosis</subject><subject>full‐core</subject><subject>Liver</subject><subject>liver biopsy</subject><subject>side‐notch</subject><subject>ultrasound</subject><issn>1386-6346</issn><issn>1872-034X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp90MFKwzAYB_AgipvTiw8gAS8idDZNmqRHGdMJE0UmeCtp-5V1ZE1N7EZvPoLP6JOYuenBg7kkfPnx5-OP0CkJh8Sfqzk0dkiojPke6hMpoiCk7GXfv6nkAaeM99CRc4swJCKM2CHqUU7jmFPeR_ezOeDWQdnqGpzDpsQK17DWHS5gBdo0UGD_qT_fP3JjAWeVaVznCRQacFVjXa3A7sbH6KBU2sHJ7h6g55vxbDQJpg-3d6PraZAzJngAcUJzJZlQkZQ5USLxSyZScAKKxZxQzhmBMiuSMoOCJAwECJIzmRVxkquEDtDFNrex5rUF95YuK5eD1qoG07o0EjQmIqIh9_T8D12Y1tZ-O69kKBjjlHp1uVW5Nc5ZKNPGVktlu5SE6abkdFNy-l2yx2e7yDZbQvFLf1r1gGzButLQ_ROVTsaPT9vQL3u-hzI</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Takeuchi, Hirohito</creator><creator>Sugimoto, Katsutoshi</creator><creator>Kakegawa, Tatsuya</creator><creator>Tomita, Yusuke</creator><creator>Takahashi, Hiroshi</creator><creator>Wada, Takuya</creator><creator>Abe, Masakazu</creator><creator>Yoshimasu, Yu</creator><creator>Matsubayashi, Jun</creator><creator>Nagao, Toshitaka</creator><creator>Itoi, Takao</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202303</creationdate><title>The usefulness of a newly developed full‐core biopsy needle in liver biopsy</title><author>Takeuchi, Hirohito ; Sugimoto, Katsutoshi ; Kakegawa, Tatsuya ; Tomita, Yusuke ; Takahashi, Hiroshi ; Wada, Takuya ; Abe, Masakazu ; Yoshimasu, Yu ; Matsubayashi, Jun ; Nagao, Toshitaka ; Itoi, Takao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4476-e593ca847a288c1a7963498761ea456136641efbd9fbed194e7e71c48bd59ca93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biopsy</topic><topic>biopsy needle</topic><topic>Fibrosis</topic><topic>full‐core</topic><topic>Liver</topic><topic>liver biopsy</topic><topic>side‐notch</topic><topic>ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeuchi, Hirohito</creatorcontrib><creatorcontrib>Sugimoto, Katsutoshi</creatorcontrib><creatorcontrib>Kakegawa, Tatsuya</creatorcontrib><creatorcontrib>Tomita, Yusuke</creatorcontrib><creatorcontrib>Takahashi, Hiroshi</creatorcontrib><creatorcontrib>Wada, Takuya</creatorcontrib><creatorcontrib>Abe, Masakazu</creatorcontrib><creatorcontrib>Yoshimasu, Yu</creatorcontrib><creatorcontrib>Matsubayashi, Jun</creatorcontrib><creatorcontrib>Nagao, Toshitaka</creatorcontrib><creatorcontrib>Itoi, Takao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeuchi, Hirohito</au><au>Sugimoto, Katsutoshi</au><au>Kakegawa, Tatsuya</au><au>Tomita, Yusuke</au><au>Takahashi, Hiroshi</au><au>Wada, Takuya</au><au>Abe, Masakazu</au><au>Yoshimasu, Yu</au><au>Matsubayashi, Jun</au><au>Nagao, Toshitaka</au><au>Itoi, Takao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The usefulness of a newly developed full‐core biopsy needle in liver biopsy</atitle><jtitle>Hepatology research</jtitle><addtitle>Hepatol Res</addtitle><date>2023-03</date><risdate>2023</risdate><volume>53</volume><issue>3</issue><spage>247</spage><epage>257</epage><pages>247-257</pages><issn>1386-6346</issn><eissn>1872-034X</eissn><abstract>Aim
To evaluate the usefulness and safety of a newly developed full‐core biopsy needle.
Methods
We selected 149 patients who underwent percutaneous liver biopsy at our institution from February 2019 to April 2021. We excluded 35 patients with hepatic fibrosis stage F3 or higher, which made it histopathologically difficult to measure the number of complete portal triads. The patients were divided into two groups as follows: 62 cases with the 18‐G conventional automated needle (TruCore needle: T needle), and 52 cases with the 18‐G full‐core needle (CorVocet needle: C needle). We measured the number of complete portal triads in the liver tissue specimens, and the sum of the length and width of the collected tissues. Moreover, we compared the number of session counts, fragmentations, and complications.
Results
The sum of the length and the width was 12.8 mm (11.2–14.3) and 15.9 mm (13.1–17.3; p < 0.001), and 0.68 mm (0.63–0.74) and 0.82 mm (0.78–0.90; p < 0.001) for the T needle and C needle, respectively. The number of complete portal triads and fragmentation was six (3–8) and 10 (6–13; p < 0.001), and one (1–10) and one (1–3; p < 0.001), for the T needle and C needle, respectively. There was one session count (1–2) in both groups; however, there were significantly higher cases of two sessions with the T needle than that with the C needle (p = 0.018). There were no serious adverse events.
Conclusions
Compared with the conventional needles, the newly developed full‐core needles enabled the acquisition of a larger amount of tissue sample in liver biopsy.</abstract><cop>Netherlands</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36355636</pmid><doi>10.1111/hepr.13856</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1386-6346 |
| ispartof | Hepatology research, 2023-03, Vol.53 (3), p.247-257 |
| issn | 1386-6346 1872-034X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2735172306 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Biopsy biopsy needle Fibrosis full‐core Liver liver biopsy side‐notch ultrasound |
| title | The usefulness of a newly developed full‐core biopsy needle in liver biopsy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A10%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20usefulness%20of%20a%20newly%20developed%20full%E2%80%90core%20biopsy%20needle%20in%20liver%20biopsy&rft.jtitle=Hepatology%20research&rft.au=Takeuchi,%20Hirohito&rft.date=2023-03&rft.volume=53&rft.issue=3&rft.spage=247&rft.epage=257&rft.pages=247-257&rft.issn=1386-6346&rft.eissn=1872-034X&rft_id=info:doi/10.1111/hepr.13856&rft_dat=%3Cproquest_cross%3E2780744633%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780744633&rft_id=info:pmid/36355636&rfr_iscdi=true |